Fore Biotherapeutics
PrivateLast Round
Series D-2
Extension
Jul 7, 2026
Est. Valuation
$75M
Total Funding Raised
$249.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Fore Biotherapeutics is a biotechnology company that develops precision oncology therapies for patients with rare, unaddressed tumor mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fore Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Fore Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D-2 Extension | Jul 7, 2026 | ||||
| Series D | May 22, 2025 | ||||
| Series D | Aug 23, 2023 | ||||
| Series C | Sep 21, 2020 | ||||
| VC Round | Apr 30, 2018 | ||||
Series A | Jun 22, 2016 |
Fore Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series D-2 Extension |
| Samsung Securities Co., Ltd. | Series D, Series D-2 Extension |
| TaiAx Capital | Series D-2 Extension |
| Bio Capital Impact Fund | VC Round |
| Cormorant Asset Management | Series D, Series C, Series D-2 Extension |
| 3B FUTURE Health Fund | Series D, Series D-2 Extension, VC Round |
| Pontifax Venture Capital | VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
$67M round led by Medicxi, SR One, and SymBiosis Capital Management.
- Jun 20, 2026
Monthly visitors increased 71% MoM.
Fore Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fore Biotherapeutics's valuation, stock price, and market status.